TI
ANAB icon

Trexquant Investment’s AnaptysBio ANAB Stock Holding History

Trexquant Investment’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Sell
35,404
-49,763
-58% -$3.02M 0.01% 1122
2026
Q1 		$4.72M Buy
85,167
+26,358
+45% +$1.42M 0.03% 671
2025
Q4 		$2.85M Sell
58,809
-52,969
-47% -$2.06M 0.03% 845
2025
Q3 		$3.42M Sell
111,778
-87,464
-44% -$2.01M 0.04% 700
2025
Q2 		$4.42M Buy
199,242
+45,679
+30% +$956K 0.05% 573
2025
Q1 		$2.85M Buy
153,563
+92,843
+153% +$1.55M 0.03% 736
2024
Q4 		$804K Sell
60,720
-37,152
-38% -$900K 0.01% 1163
2024
Q3 		$3.28M Buy
97,872
+71,158
+266% +$2.43M 0.04% 637
2024
Q2 		$669K Sell
26,714
-5,803
-18% -$135K 0.01% 1145
2024
Q1 		$732K Buy
32,517
+10,685
+49% +$253K 0.01% 1031
2023
Q4 		$468K Buy
21,832
+11,318
+108% +$195K 0.01% 1104
2023
Q3 		$189K Buy
+10,514
New +$201K ﹤0.01% 1350
2023
Q2 		– Sell
-23,603
Closed -$514K – 1406
2023
Q1 		$514K Buy
+23,603
New +$574K 0.01% 986
2020
Q1 		– Sell
-20,153
Closed -$327K – 1075
2019
Q4 		$327K Buy
20,153
+11,385
+130% +$269K 0.02% 708
2019
Q3 		$307K Buy
+8,768
New +$417K 0.03% 610
2019
Q2 		– Sell
-6,774
Closed -$495K – 782
2019
Q1 		$495K Buy
6,774
+3,293
+95% +$227K 0.04% 588
2018
Q4 		$222K Buy
+3,481
New +$259K 0.01% 878
2018
Q2 		– Sell
-4,760
Closed -$495K – 878
2018
Q1 		$495K Buy
+4,760
New +$536K 0.03% 637

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Trexquant Investment's ANAB Position: Q2 2026 in Review

Trexquant Investment reduced its AnaptysBio (ANAB) stake by 58% in Q2 2026, selling an estimated $3.02M and leaving 35,404 shares worth $2.39M. The position accounts for 0.01% of the portfolio, ranked #1122.

Trexquant Investment first reported a position in ANAB in Q1 2018 and has held it in 18 quarters since. The position peaked at $4.72M in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Trexquant Investment held 35,404 shares of AnaptysBio worth $2.39M as of Q2 2026.
  • Trexquant Investment sold 49,763 AnaptysBio shares in Q2 2026, an estimated $3.02M.
  • AnaptysBio made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1122 holding.
  • Trexquant Investment first reported a position in AnaptysBio in Q1 2018 and has held it in 18 quarters since.
  • Trexquant Investment's AnaptysBio position peaked at $4.72M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.